Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systems

Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systems

US Patent 8623999 · Granted Jan 7, 2014

Estimated economic value: $48,591,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyrimidines as EED inhibitors and the use thereof2024
Anti-CD39 antibodies and use thereof2024
Fused 1,4-oxazepines as BET protein degraders2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
BET bromodomain protein degraders with cleavable linkers2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and2022
Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and2022
Microneedle array with active ingredient2021
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyper2021